Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2026-05-13 @ 6:51 PM
Study NCT ID:
NCT02782403
Status:
TERMINATED
Last Update Posted:
2020-11-19
First Post:
2016-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Accelerated Phase Chronic Myelogenous Leukemia (CML) | View |
| None | Blast Phase Chronic Myelogenous Leukemia (CML) | View |
| None | Chronic Phase Phase Chronic Myelogenous Leukemia (CML) | View |
| None | Philadelphia Chromosome Positive (Ph+) Phase Chronic Myelogenous Leukemia (CML) | View |
Keywords: